A predictive model was developed and validated to assess the risk of seizure recurrence after discontinuation of antiseizure medication in pediatric epilepsy patients. The model identified nine independent risk factors and demonstrated strong discriminatory performance, offering a robust tool for estimating seizure recurrence risk. The authors emphasized the importance of individualized treatment planning and suggested external validation of the model across diverse clinical settings and populations.

Source: eClinicalMedicine